###begin article-title 0
###xml 46 51 <span type="species:ncbi:10090">Mouse</span>
Estrogen/Estrogen Receptor Alpha Signaling in Mouse Posterofrontal Cranial Suture Fusion
###end article-title 0
###begin p 1
Conceived and designed the experiments: AWJ AAT SAB YX ALC PL KK MTL. Performed the experiments: AWJ AAT SAB YX ALC PL KH. Analyzed the data: AWJ AAT SAB YX ALC PL KH. Contributed reagents/materials/analysis tools: KK MTL. Wrote the paper: AWJ AAT SAB YX ALC PL KH KK MTL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
While premature suture fusion, or craniosynostosis, is a relatively common condition, the cause is often unknown. Estrogens are associated with growth plate fusion of endochondral bones. In the following study, we explore the previously unknown significance of estrogen/estrogen receptor signaling in cranial suture biology.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 500 508 490 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 519 526 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 630 637 620 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 660 667 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 676 682 662 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 845 853 821 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1024 1031 997 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 614 619 <span type="species:ncbi:10090">mouse</span>
###xml 791 796 <span type="species:ncbi:10090">mouse</span>
Firstly, estrogen receptor (ER) expression was examined in physiologically fusing (posterofrontal) and patent (sagittal) mouse cranial sutures by quantitative RT-PCR. Next, the cranial suture phenotype of ER alpha and ER beta knockout (alphaERKO, betaERKO) mice was studied. Subsequently, mouse suture-derived mesenchymal cells (SMCs) were isolated; the effects of 17-beta estradiol or the estrogen antagonist Fulvestrant on gene expression, osteogenic and chondrogenic differentiation were examined in vitro. Finally, in vivo experiments were performed in which Fulvestrant was administered subcutaneously to the mouse calvaria. Results showed that increased ERalpha but not ERbeta transcript abundance temporally coincided with posterofrontal suture fusion. The alphaERKO but not betaERKO mouse exhibited delayed posterofrontal suture fusion. In vitro, addition of 17-beta estradiol enhanced both osteogenic and chondrogenic differentiation in suture-derived mesenchymal cells, effects reversible by Fulvestrant. Finally, in vivo application of Fulvestrant significantly diminished calvarial osteogenesis, inhibiting suture fusion.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 130 138 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Estrogen signaling through ERalpha but not ERbeta is associated with and necessary for normal mouse posterofrontal suture fusion. In vitro studies suggest that estrogens may play a role in osteoblast and/or chondrocyte differentiation within the cranial suture complex.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Farkas1">[1]</xref>
###xml 268 271 268 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Panchal1">[2]</xref>
###xml 506 509 506 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lenton1">[3]</xref>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
Craniosynostosis, or the premature osseous obliteration of cranial sutures, is a relatively common craniofacial defect, with an incidence of 1 in 2500 live births [1]. Its clinical sequelae can be significant, and include both morphologic and functional abnormalities [2]. Our laboratory has investigated the mechanisms of cranial suture fusion using a mouse model, with the hopes that a more thorough understanding of physiologic suture fusion may lead toward novel therapeutics for pathologic synostosis [3].
###end p 9
###begin p 10
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lenton1">[3]</xref>
###xml 172 175 172 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sahar1">[4]</xref>
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sahar1">[4]</xref>
###xml 386 389 386 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Manzanares1">[5]</xref>
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Kokich1">[6]</xref>
###xml 698 701 695 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James1">[7]</xref>
###xml 702 706 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Opperman1">[11]</xref>
###xml 907 911 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lin1">[12]</xref>
###xml 913 917 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lin2">[13]</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
In the mouse, the posterofrontal (PF) suture fuses in the first weeks of life, whereas all other sutures remain patent, including the contiguous sagittal (SAG) suture [3], [4]. The PF suture normally fuses through a cartilage intermediate, or via endochondral ossification [4]. In these respects, the mouse PF suture is analogous to the human metopic suture, which fuses during infancy [5], [6]. The molecular comparison of PF and SAG cranial sutures, as exemplars of normal suture fusion and suture patency, respectively, has led to the identification of differences in locally acting cytokines between fusing and patent sutures, including FGF-2, IGFs, TGF-betas, and BMP agonists and antagonists [7]-[11]. While much study has focused on the role of autocrine and paracrine signaling in cranial suture biology, the role of endocrine signaling in suture formation and fusion has been relatively unexplored [12], [13].
###end p 10
###begin p 11
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-McCauley1">[14]</xref>
###xml 330 334 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-vanderEerden1">[15]</xref>
###xml 335 339 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Egerbacher1">[18]</xref>
###xml 568 572 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Chagin1">[19]</xref>
###xml 752 756 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Grumbach1">[20]</xref>
###xml 758 762 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Grumbach2">[21]</xref>
Estrogens have been shown to be important in the development and maintenance of the appendicular skeleton [14]. Estrogens have two known nuclear receptors, estrogen receptor (ER) alpha and beta. Both receptors are present in the epiphyseal growth plate, specifically in hypertrophic chondrocytes, as well as adjacent bony tissues [15]-[18]. The mechanisms by which estrogens act locally on the growth plate are poorly understood. It has been proposed that estrogen initiates the pubertal growth spurt by stimulating chondrogenesis and inhibiting chondrocyte apoptosis [19]. Additionally, estrogens are postulated to contribute to growth plate fusion via endochondral ossification, possibly by estrogen-induced vasculogenesis and/or osteoblast invasion [20], [21].
###end p 11
###begin p 12
###xml 414 418 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-McCauley1">[14]</xref>
###xml 420 424 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-McCauley2">[22]</xref>
###xml 425 429 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Parikka1">[26]</xref>
###xml 536 540 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Parikka1">[26]</xref>
###xml 713 717 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Vidal1">[24]</xref>
###xml 719 723 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Chagin2">[27]</xref>
###xml 725 729 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Chagin3">[28]</xref>
###xml 945 949 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Smith1">[29]</xref>
###xml 950 954 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Smith2">[31]</xref>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 568 573 <span type="species:ncbi:10090">mouse</span>
###xml 731 736 <span type="species:ncbi:9606">Human</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 822 830 <span type="species:ncbi:9606">patients</span>
Despite the imprecise role of estrogen in growth plate fusion, perturbations of estrogen signaling indicate its importance. Both the ERalpha and ERbeta knockout mice (alphaERKO and betaERKO) possess a skeletal phenotype. The alphaERKO mouse has been observed to have a more severe phenotype, including reduced bone mineral density and bone mineral content, as well as decreased longitudinal and radial bone growth [14], [22]-[26]. Absence of the tibial growth plate cartilages has also been previously observed in female alphaERKO mice [26]. In contrast, the betaERKO mouse has been observed to have a relatively minor phenotype, reported either to have normal or increased appendicular and axial-skeletal growth [24], [27], [28]. Human perturbations in estrogen signaling have been observed to differ from those in mice: patients with mutations in ERalpha or aromatase P-450 present with delayed or incomplete ossification of the growth plates [29]-[31]. While estrogen's involvement in longitudinal bone growth has been studied in depth, its role in cranial suture biology has not been defined. We hypothesized that estrogen may influence the PF suture in a similar manner to its role in ossification of the epiphyseal plate.
###end p 12
###begin p 13
###xml 325 333 318 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 534 541 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
In this study, we first examined temporal and spatial patterns of ER expression in the posterofrontal (PF, fusing) and sagittal (SAG, patent) sutures. Next, we inquired as to the necessity of estrogen signaling in cranial suture fusion by examining the suture phenotype of the alphaERKO and betaERKO mutant mice. We employed in vitro culture of calvarial-derived cells to explore in detail the cellular impacts of estrogen signaling, utilizing both 17-beta estradiol (E2) and the pan-ER antagonist Fulvestrant (ICI 182,780). Finally, in vivo biochemical perturbations were performed by applying Fulvestrant to developing wild-type cranial sutures.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Gross and histological morphology of Posterofrontal and Sagittal cranial sutures
###end title 15
###begin p 16
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sahar1">[4]</xref>
###xml 369 376 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s001">Fig. S1</xref>
###xml 480 488 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s001">Fig. S1A</xref>
###xml 561 569 561 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s001">Fig. S1A</xref>
###xml 694 702 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s001">Fig. S1C</xref>
###xml 808 816 808 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s001">Fig. S1F</xref>
###xml 902 910 902 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s001">Fig. S1A</xref>
###xml 351 356 <span type="species:ncbi:10090">mouse</span>
###xml 386 392 <span type="species:ncbi:10090">murine</span>
Our laboratory has previously identified a timeline of normal PF suture fusion: the initiation of fusion occurs at or around postnatal day 7 (p7), the most prominent cartilaginous intermediate is observed at p10, and osseous closure is for the most part complete by p19 [4]. We sought to confirm this by whole mount bone and cartilage preparations of mouse calvariae, (Fig. S1). In the murine skull, the PF suture lies anterior to the contiguous SAG suture, which lies posterior (Fig. S1A). At p4, the calvarial bones are widely separated by suture mesenchyme (Fig. S1A). Intermittent bony bridging of the PF suture is apparent at or around p10, primarily in the anterior aspect of the suture (Fig. S1C). By p19, the majority of the PF suture has undergone osseous fusion, with intermittent gaps of patency (Fig. S1F). In contrast, the SAG suture remains patent in its entirety, throughout adult life (Fig. S1A-F).
###end p 16
###begin p 17
###xml 80 87 80 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s002">Fig. S2</xref>
###xml 530 538 530 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s002">Fig. S2A</xref>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s002">Fig. S2C</xref>
###xml 784 792 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s002">Fig. S2O</xref>
###xml 994 1002 994 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s002">Fig. S2G</xref>
Histological analysis of PF and SAG sutures reveals more developmental detail, (Fig. S2). Pentachrome staining was performed at identical time points (p4-p19), in which bone appears yellow, while cartilage appears blue/green. As the histologic appearance of PF and SAG sutures exhibits variation along the anterior-posterior axis, representative sections from the anterior aspect of each suture were chosen. At p4, the osteogenic fronts of both PF and SAG sutures are widely separated by an undifferentiated cellular mesenchyme, (Fig. S2A,B,G,H). From p7 to p10, a blue/green cartilaginous intermediate appears on the endocranial aspect of the PF suture (Fig. S2C-F). At p16 onwards, the endocranial mesenchyme of the PF suture is replaced by bony tissue seen as yellow (i.e. fused) (Fig. S2O-R). In contrast, the osteogenic fronts of the SAG suture remain separated by a cellular mesenchyme at all time points (i.e. patent), and either appear in an end-to-end or slightly overlapping fashion (Fig. S2G-L,S-X).
###end p 17
###begin title 18
Estrogen receptor gene expression in PF and SAG cranial sutures
###end title 18
###begin p 19
###xml 142 149 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 154 160 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 231 240 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1A,B</xref>
###xml 243 250 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 263 270 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 369 376 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1A</xref>
###xml 421 428 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 502 512 487 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1A, N</xref>
###xml 571 578 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 686 693 667 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1A</xref>
###xml 696 697 677 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 717 724 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 864 871 841 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1A</xref>
###xml 874 875 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 883 890 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 974 981 947 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1A</xref>
###xml 984 985 957 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 999 1006 972 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 1057 1063 1026 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 1151 1158 1117 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1B</xref>
###xml 1213 1243 1179 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sex determining region Y-box 9</italic>
###xml 1245 1249 1211 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 1272 1279 1238 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1C</xref>
###xml 1324 1328 1290 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 1333 1340 1299 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 1466 1473 1428 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1C</xref>
###xml 1484 1503 1446 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s002">Supplemental Fig. 2</xref>
###xml 1513 1514 1475 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1530 1534 1492 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 1608 1611 1570 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sahar1">[4]</xref>
###xml 1687 1692 <span type="species:ncbi:10090">mouse</span>
Having confirmed a timeline for PF suture fusion, estrogen receptor expression was examined by qRT-PCR. Expression of both nuclear receptors, ERalpha and ERbeta, was assayed in PF (fusing) as well as SAG (patent) cranial sutures, (Fig. 1A,B). Results showed that ERalpha transcript abundance in the PF suture increased over the time course of suture fusion, (red bars, Fig. 1A). Before the process of suture fusion (p4), ERalpha expression was approximately equal between PF and SAG sutures (far left, Fig. 1A, N = 10). From p4 to p10, a greater than 12-fold increase in ERalpha was observed, (corresponding to a time period of growth and chondrogenesis within the PF suture, (red bars Fig. 1A, *P<0.01). Thereafter, ERalpha expression gradually decreased, but remained significantly elevated, (a time period corresponding to gradual suture ossification, red bars Fig. 1A, *P<0.01). ERalpha expression was present to a lesser degree in the non-fusing SAG suture, (blue bars Fig. 1A, #P<0.01). While ERalpha expression peaked during fusion of the PF suture, ERbeta expression remained relatively constant overtime in both PF and SAG suture complexes, (Fig. 1B). Expression of the chondrogenic transcription factor Sex determining region Y-box 9 (Sox9) was also evaluated, (Fig. 1C). The peak in transcript abundance for both Sox9 and ERalpha temporally coincided at p10, a time point at which histological evidence of chondrocytes is most apparent in the PF suture, (Fig. 1C, see also Supplemental Fig. 2,E,F, N, *P<0.01). Data of Sox9 expression are in agreement with previous observations by our laboratory [4]. In summary, these data temporally associated ERalpha gene expression with mouse PF suture fusion.
###end p 19
###begin title 20
Estrogen receptor alpha and beta expression in PF and SAG sutures.
###end title 20
###begin p 21
###xml 4 11 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 76 81 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 273 279 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 333 338 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 442 446 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 500 505 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1216 1220 1189 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#8804;</italic>
(A) ERalpha gene expression in PF and SAG sutures by qRT-PCR, normalized to GAPDH. Expression increased over 12-fold from postnatal ages 4 to 10 in the fusing PF suture, see red bars. Highest expression was noted at p10, temporally corresponding with PF suture fusion. (B) ERbeta gene expression in PF and SAG sutures, normalized to GAPDH. Expression remained relatively constant over the time course examined in both PF and SAG sutures. (C) Sox9 gene expression in PF and SAG sutures, normalized to GAPDH. (D) Pentachrome staining of the p7 PF suture in which cartilage appears blue/green, while bone appears yellow. (E) ERalpha immunohistochemistry of p7 PF suture. Nuclear ERalpha protein strongly localizes to hypertrophic chondrocytes within the PF suture; dashed lines indicate the fusing inner bone table of the suture. (F) Negative control for ERalpha immunohistochemistry. (G) Pentachrome staining of the p7 SAG suture. (H) ERalpha immunohistochemistry of p7 SAG suture. Dashed lines indicate the adjacent osteogenic fronts of the patent suture. (I) Negative control for ERalpha immunohistochemistry. Gene expression values are normalized to expression within the p4 SAG suture complex, N = 10, *, **, and #P</=0.01 in which * signifies differences between the PF suture at various timepoints, ** between SAG suture at various timepoints, and # between PF and SAG sutures at the same timepoint. Histological sections are from the anterior aspect of PF and SAG sutures, presented at 40x magnification.
###end p 21
###begin title 22
Estrogen receptor protein expression in PF and SAG cranial sutures
###end title 22
###begin p 23
###xml 36 43 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 199 208 191 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1D&#8211;I</xref>
###xml 351 358 339 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1E</xref>
###xml 654 661 638 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1H</xref>
###xml 736 745 720 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1D,G</xref>
###xml 826 835 810 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1F,I</xref>
###xml 1029 1033 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-vanderEerden1">[15]</xref>
###xml 1035 1039 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-vanderEerden2">[16]</xref>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 1017 1023 <span type="species:ncbi:10090">murine</span>
Having observed a dynamic change in ERalpha gene expression, we next examined the spatial distribution of ERalpha protein expression in the fusing PF and patent SAG sutures, by immunohistochemistry (Fig. 1D-I). In the PF suture, strong nuclear staining for ERalpha was observed most prominently in hypertrophic chondrocytes in the suture mesenchyme, (Fig. 1E). Less prominent staining was observed within the pericranium, as well as osteoblasts lining and osteocytes within the frontal bones. For comparison in the SAG suture, immunostaining for ERalpha protein was limited to those cells encircling the osteogenic fronts of the growing parietal bones, (Fig. 1H). Pentachrome staining of adjacent sections are provided for orientation (Fig. 1D,G); negative controls without exposure to primary antibody are presented as well (Fig. 1F,I). Notably, no significant differences in staining for ERs were observed between sutures taken from male or female mice, a finding similar to previously published observation in the murine tiba [15], [16]. In summary, ERalpha protein is expressed in both PF and SAG sutures. Its spatial distribution suggests that cells undergoing both osteogenesis and chondrogenesis within the developing cranial suture expressed ER protein. In addition, cells within the suture mesenchyme of the non-fusing SAG suture stained to a relatively lesser degree for ER protein than chondrocytes within the fusing PF suture.
###end p 23
###begin title 24
###xml 28 32 <span type="species:ncbi:10090">mice</span>
ERalpha but not ERbeta null mice exhibit delayed PF suture fusion
###end title 24
###begin p 25
###xml 492 494 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 542 548 535 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2</xref>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
While ER expression was associated with PF suture fusion, the necessity of ER signaling in suture fusion had not yet been assessed. For this purpose, genetic knockout mice were analyzed lacking either functional ERalpha or ERbeta. Analysis of the PF suture was performed at postnatal time points spanning the process of suture fusion: p10, p16 and p30. As the PF suture exhibits variation in development along its anterior-posterior axis, the entirety of each suture was sectioned and every 5th section was stained for histological analysis (Fig. 2).
###end p 25
###begin title 26
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
PF suture phenotype in alphaERKO mouse.
###end title 26
###begin p 27
###xml 417 424 409 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 443 448 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 624 631 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 650 653 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 807 810 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 1111 1113 1084 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1479 1480 1448 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Wild-type (WT) p10 PF suture. Hypertrophic chondrocytes, seen here as blue/green, are observed to bridge the gap between osteogenic fronts of the suture. (B) alphaERKO p10 PF suture. A complete absence of cartilage is observed, despite proximity of the osteogenic fronts. (C) PCNA immunohistochemistry in the WT p10 PF suture. (D) PCNA staining in the alphaERKO p10 PF suture showed relatively less staining. (E) In situ hybridization for Runx2 in the WT p10 frontal bone. Strong staining was noted in the cells lining and within the bone. (F) In comparison, less staining was observed in the alphaERKO frontal bone (G) In situ hybridization for Shh in the WT p10 PF suture. Strong staining was noted in the hypertrophic chondrocytes within the suture mesenchyme. (H) In comparison, little staining for Shh was noted in the alphaERKO p10 PF suture. (I) WT p16 PF suture. Note normal osseous fusion on the endocranial aspect. (J) alphaERKO p16 PF suture. Suture patency is apparent on both endo- and ectocranial aspects. (K) Mean percentage suture fusion in WT, alphaERKO and betaERKO PF p16 sutures. Every 5th coronal section of the suture was stained; two blinded, independent observers judged fusion or patency along the length of the suture. (L) Relative gene expression in WT as compared to alphaERKO whole skulls at 7d of life, as determined by qRT-PCR. Averages and standard deviations were calculated, significance calculated relative to wild-type percentage fusion, *P<0.01. For histological specimens, sections presented are taken from the anterior aspect of the PF suture, presented at 20x-40x magnification.
###end p 27
###begin p 28
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2A</xref>
###xml 360 367 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2B</xref>
###xml 539 548 531 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2C,D</xref>
###xml 607 614 599 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 630 639 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2E&#8211;H</xref>
###xml 736 741 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 818 827 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2E,F</xref>
###xml 920 934 908 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sonic Hedgehog</italic>
###xml 936 939 924 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 945 952 933 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 968 975 956 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2G</xref>
###xml 998 1001 986 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 1054 1061 1038 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2H</xref>
###xml 1172 1179 1156 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2I</xref>
###xml 1255 1262 1235 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2J</xref>
###xml 1323 1325 1303 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1369 1376 1345 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 1570 1577 1542 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2K</xref>
###xml 1580 1581 1552 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1991 1998 1956 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2K</xref>
###xml 1642 1646 <span type="species:ncbi:10090">mice</span>
###xml 2124 2128 <span type="species:ncbi:10090">mice</span>
###xml 2225 2230 <span type="species:ncbi:10090">mouse</span>
In the p10 PF wild-type (WT) suture a large cartilaginous intermediate was normally observed within the mid-sutural space (Fig. 2A). Cartilage was observed in the majority of sections, and found in all WT sutures (5/5 specimens). In the corresponding alphaERKO sutures, the PF suture was observed to be patent throughout and without a cartilage intermediate, (Fig. 2B) (3/3 specimens). Cellular proliferation was assayed in WT and alphaERKO by PCNA immunostaining, which showed a relative paucity of PCNA+ cells in the knockout PF suture (Fig. 2C,D). Further difference in gene expression were evaluated by in situ hybridization (Fig. 2E-H). In the WT frontal bone, those cells lining and within the calvarial bone stained strongly for Runx2, while relatively less staining was observed in the alphaERKO frontal bone (Fig. 2E,F). Moreover, in the WT PF suture, hypertrophic chondrocytes were noted to stain strongly for Sonic Hedgehog (Shh), by in situ hybridization (Fig. 2G). In contrast, little Shh expression was observed in the alphaERKO PF suture (Fig. 2H). By postnatal day 16, the majority of the WT PF suture exhibited osseous fusion on the endocranial surface, (Fig. 2I). In contrast, only sporadic fusion was noted in the alphaERKO PF suture, (Fig. 2J). Percentage fusion was calculated by examination of every 5th slide (N = 5 WT, N = 3 alphaERKO sutures). Results showed that the majority of the WT PF suture exhibited fusion along its anterior-posterior axis by p16 (66%), whereas on average only 12% of the alphaERKO PF suture was fused along its length (Fig. 2K, *P<0.01). This difference in PF fusion was observed in 30d old mice as well: while osseous fusion was apparent throughout the length of the PF suture in the WT and with only small gaps of patency (N = 4), only the anterior portion of alphaERKO PF suture showed evidence of fusion and osteogenic fronts remained separated (data not shown). Analysis of the betaERKO PF suture revealed no difference to WT sutures (Fig. 2K for quantization). Moreover, no differences in SAG suture morphology were observed between wild-type, alphaERKO, or betaERKO mice (data not shown). Collectively, these data demonstrated that the alphaERKO but not the betaERKO mouse exhibited delayed fusion of the PF suture, without evidence of a chondrocytic intermediate and with diminished Hedgehog expression.
###end p 28
###begin p 29
###xml 301 312 293 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2, Sox9</italic>
###xml 317 343 309 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">alkaline phosphatase (ALP)</italic>
###xml 345 352 337 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2L</xref>
###xml 408 417 400 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMP-2, -4</italic>
###xml 424 425 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</italic>
###xml 438 452 430 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sonic Hedgehog</italic>
###xml 482 489 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2L</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
To verify differences between wild-type and alphaERKO mice observed by histology, gene expression in whole skulls was examined in 7d old littermates. Briefly, numerous genes involved in osteochondrogenic differentiation were observed to be decreased in expression in the alphaERKO calvaria, including Runx2, Sox9 and alkaline phosphatase (ALP) (Fig. 2L). Moreover, growth and differentiation factors such as BMP-2, -4, and -7, as well as Sonic Hedgehog were down-regulated as well (Fig. 2L, right).
###end p 29
###begin p 30
###xml 231 239 227 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 345 348 341 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James1">[7]</xref>
###xml 350 353 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Xu1">[8]</xref>
###xml 355 359 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James2">[32]</xref>
###xml 361 369 357 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
While ERalpha mutations resulted in a mouse suture phenotype, the underlying mechanisms that translated a biochemical deficiency into a craniofacial dysmorphism remained unclear. To elucidate possible mechanisms, we next turned to in vitro culture of suture-derived mesenchymal cells (SMCs), of which the procedure has been previously described [7], [8], [32]. In vitro, estrogen signaling was either artificially increased with the addition of 17-beta estradiol (E2), or decreased with addition of the synthetic, pan-ER antagonist Fulvestrant (ICI 182,780).
###end p 30
###begin title 31
17-beta Estradiol increases cellular proliferation of PF suture-derived mesenchymal cells, reversible by Fulvestrant
###end title 31
###begin p 32
###xml 201 223 201 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s002">Supplemental Fig. 2A,B</xref>
###xml 382 390 382 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 559 565 559 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g003">Fig. 3</xref>
###xml 642 649 642 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g003">Fig. 3A</xref>
###xml 670 671 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 785 792 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g003">Fig. 3B</xref>
###xml 888 895 888 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g003">Fig. 3B</xref>
###xml 938 940 938 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
Posterofrontal suture-derived mesenchymal cells (SMCs) were isolated from p4 animals, a time period where the PF suture is widely patent, separated by an undifferentiated cellular mesenchyme (see also Supplemental Fig. 2A,B for histology). To assess the effects of estrogen signaling in SMCs, both E2 and the ER antagonist Fulvestrant were added to medium, alone or in combination; in vitro studies included proliferation, osteogenic and chondrogenic differentiation assays. Effects on cellular proliferation were first examined by BrdU incorporation assays (Fig. 3). At both 3 and 6d growth, E2 was observed to increase BrdU incorporation, (Fig. 3A, 0.1-10 nM, N = 6, *P<0.01). No effect was observed with blockade of estrogen signaling via Fulvestrant addition to medium alone (left Fig. 3B, 0.1-10 uM). By combining Fulvestrant with E2, the mitogenic effect of E2 was reversed, (right Fig. 3B, 10 nM estradiol, 0.1-10 uM Fulvestrant, *P<0.01).
###end p 32
###begin title 33
Cellular proliferation of PF SMCs with 17-beta Estradiol and Fulvestrant.
###end title 33
###begin p 34
###xml 644 646 632 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
After 3 and 6d growth with or without 17-beta estradiol (0.1-100 nM), BrdU incorporation assays were performed to evaluate cellular proliferation. (A) BrdU incorporation with or without 17-beta estradiol. Treatment with 17-beta estradiol (E2) resulted in increased proliferation (0.1-10 nM). (B) BrdU incorporation after 6d growth with Fulvestrant alone or in combination with 17-beta estradiol. Fulvestrant alone showed no effect on BrdU uptake (left), while in combination with E2 was observed to reverse the mitogenic effect of E2 (right). Values are normalized and significance levels calculated relative to control groups in grey, N = 6, *P<0.01.
###end p 34
###begin title 35
17-beta Estradiol increases osteogenic differentiation of PF suture-derived mesenchymal cells
###end title 35
###begin p 36
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Chow1">[33]</xref>
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Okazaki1">[39]</xref>
###xml 168 175 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 180 186 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 372 379 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 384 390 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 449 459 435 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4A, N</xref>
###xml 466 467 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 474 478 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Hong1">[37]</xref>
###xml 480 484 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Tang1">[40]</xref>
###xml 643 652 629 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4B,C</xref>
###xml 655 662 641 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 807 819 793 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4B,C, N</xref>
###xml 826 827 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 982 994 968 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4B,D, N</xref>
###xml 1001 1002 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1118 1127 1104 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4B,D</xref>
###xml 1227 1235 1213 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1250 1257 1236 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4E</xref>
###xml 1317 1341 1303 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Runx2, ALP, Col1&#945;1)</italic>
###xml 1382 1395 1364 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Osteocalcin)</italic>
###xml 1494 1504 1476 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4E, N</xref>
###xml 1511 1512 1493 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Estrogens have been shown to promote osteogenesis in disparate cell types, both in vitro and in vivo[33]-[39]. To assess the osteogenic effects of E2 on SMCs, firstly, ERalpha and ERbeta gene expression were evaluated throughout osteogenic differentiation (0, 1 and 2 wks in osteogenic differentiation medium). As has been reported in other cell types, expression of both ERalpha and ERbeta were observed to increase overtime in osteogenic medium, (Fig. 4A, N = 3, *P<0.01) [37], [40]. After 7d differentiation, staining and quantification of alkaline phosphatase (ALP) activity was performed as an early marker of osteogenic differentiation (Fig. 4B,C). Results showed that E2 increased both the intensity of ALP staining, and absolute value of enzymatic activity when normalized to total protein content (Fig. 4B,C, N = 3, *P<0.01). Terminal osteogenic differentiation was assessed at 14d differentiation, by Alizarin red staining of bone nodules and colorimetric quantification (Fig. 4B,D, N = 3, *P<0.01). Congruent with ALP activity, Alizarin Red staining demonstrated a dose-dependent increase with E2 addition (Fig. 4B,D). Gene expression of osteogenic specific markers was assessed to verify E2 mediated enhancement of in vitro osteogenesis (Fig. 4E). Consistent results were obtained both with early markers (Runx2, ALP, Col1alpha1) and terminal markers of differentiation (Osteocalcin): each showed a significant increase in expression with E2 as compared to osteogenic medium alone (Fig. 4E, N = 3, *P<0.01). Thus, E2 addition to osteogenic medium enhanced SMC osteogenic differentiation.
###end p 36
###begin title 37
Osteogenic differentiation of PF SMCs with 17-beta Estradiol.
###end title 37
###begin p 38
###xml 4 11 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 16 22 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 550 560 543 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2, ALP</italic>
###xml 565 574 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1&#945;</italic>
###xml 629 640 618 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin</italic>
###xml 702 712 691 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2, Bmp4</italic>
###xml 717 721 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp7</italic>
###xml 779 793 768 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh, Ihh, Gli1</italic>
###xml 798 802 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc1</italic>
###xml 1070 1071 1059 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) ERalpha and ERbeta expression throughout osteogenic differentiation (0, 1 and 2 wks). (B, left) Enzymatic alkaline phosphatase activity normalized to total protein content after 7d differentiation with or without E2. (B, right) Photometric quantification of Alizarin red staining after 14d differentiation with or without E2. (C) Alkaline phosphatase staining with or without E2 after 7d differentiation. (D) Alizarin red staining with or without E2 after 14d differentiation. (E, left) Expression of early markers of osteogenic differentiation (Runx2, ALP and Col1alpha) at 4d differentiation with or without E2. (E, right) Osteocalcin expression after 14d differentiation with or without E2. (F) Bmp2, Bmp4 and Bmp7 expression at 4d differentiation with or without E2. (G) Shh, Ihh, Gli1 and Ptc1 expression at 4d differentiation with or without E2. Values are normalized and significance levels calculated relative to control groups in grey or 0 wk expression levels in blue, photos are representative of random microscopical fields at 20x magnification, N = 3, *P<0.01.
###end p 38
###begin p 39
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Chen1">[41]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Zhou1">[38]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Kousteni1">[42]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Yamamoto1">[45]</xref>
###xml 393 409 393 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2, -4, and -7</italic>
###xml 531 541 531 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4F, N</xref>
###xml 548 549 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 724 732 724 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 737 744 737 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-vanderHorst1">[46]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-StJacques1">[50]</xref>
###xml 810 818 810 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh, Ihh</italic>
###xml 855 865 855 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc1, Gli1</italic>
###xml 960 964 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Koga1">[51]</xref>
###xml 1047 1057 1047 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4G, N</xref>
###xml 1064 1065 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Bone morphogenetic proteins (BMP)-2, -4 and -7 are members of the BMP family important in osteogenic differentiation [41]. Molecular studies have indicated that E2 may promote osteogenic differentiation in some cell types by promoting transcription of pro-osteogenic bone morphogenetic proteins (BMPs); we sought to investigate whether the same is true in SMCs [38], [42]-[45]. Interestingly, Bmp2, -4, and -7 expression was observed to increase with E2 addition to medium; a 2-4 fold up-regulation in each cytokine was observed, (Fig. 4F, N = 3, *P<0.01). Hedgehog signaling via either Sonic Hedgehog (Shh) or Indian Hedgehog (Ihh) has been observed to be of importance in both osteogenic and chondrogenic differentiation, in vitro and in vivo[46]-[50]. We next evaluated gene expression of Hedgehog ligands (Shh, Ihh) and downstream signaling elements (Ptc1, Gli1) after E2 treatment, by qRT-PCR. Interestingly, and as has been described in other cell types [51], E2 increased transcript abundance for all Hedgehog signaling elements examined, (Fig. 4G, N = 3, *P<0.01). This suggested that the pro-osteogenic effect of E2 in SMCs may be, in part, due to increased transcription of BMP and Hh family members.
###end p 39
###begin title 40
Fulvestrant decreases osteogenic differentiation of PF suture-derived mesenchymal cells
###end title 40
###begin p 41
###xml 201 209 201 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 312 318 312 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g005">Fig. 5</xref>
###xml 420 428 420 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Foo1">[52]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Hofbauer1">[54]</xref>
###xml 508 517 508 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g005">Fig. 5A,B</xref>
###xml 832 842 832 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g005">Fig. 5C, N</xref>
###xml 856 857 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1098 1108 1098 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g005">Fig. 5C, N</xref>
###xml 1116 1117 1116 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1285 1323 1285 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2, Col1a, Osteopontin, Osteocalcin</italic>
###xml 1325 1335 1325 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g005">Fig. 5D, N</xref>
###xml 1342 1343 1342 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1491 1497 1491 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4</xref>
###xml 1633 1653 1633 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2, Bmp4, Shh, Ihh</italic>
###xml 1701 1711 1701 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gli1, Ptc1</italic>
###xml 1726 1738 1726 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g005">Fig. 5E,F, N</xref>
###xml 1745 1746 1745 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1832 1840 1832 1840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Having shown that E2 positively influences SMC osteogenic differentiation, we next inquired as to whether the converse was true: whether blockade of endogenous estrogen signaling negatively influenced in vitro osteogenesis. Fulvestrant, a synthetic pan-ER antagonist, was added to osteogenic culture conditions (Fig. 5). Fulvestrant has been observed to decrease osteogenic differentiation of various bone forming cells in vitro[52]-[54]. Staining for ALP and Alizarin red was performed as previously shown (Fig. 5A,B). While SMCs in osteogenic medium alone showed relatively abundant staining, Fulvestrant when added at all concentrations diminished the intensity of staining for both ALP and Alizarin red staining (N = 3, 1-10 uM). Quantification of enzymatic ALP activity was next performed with Fulvestrant, with or without E2 (Fig. 5C, N = 3, * and **P<0.01). Similar to results from biochemical staining, ALP enzymatic activity was significantly reduced with Fulvestrant. Moreover, E2 mediated up-regulation of ALP activity was reversed by addition of Fulvestrant in combination (yellow bars Fig. 5C, N = 3, **P<0.01). Specific gene expression was examined by qRT-PCR, demonstrating a significant decrease in gene markers of early as well as terminal osteogenic differentiation (Runx2, Col1a, Osteopontin, Osteocalcin, Fig. 5D, N = 3, *P<0.01). We observed previously that culture with E2 significantly increased a number of pro-osteogenic cytokines, including BMP and Hh ligands (see Fig. 4). Interestingly, we found the converse to be true as well: culture with Fulvestrant resulted in a decrease in transcript abundance for Bmp2, Bmp4, Shh, Ihh as well as downstream Hh signaling components (Gli1, Ptc1), by qRT-PCR (Fig. 5E,F, N = 3, *P<0.01). Thus, these data suggested that inhibition of endogenous ER signaling impedes in vitro SMC osteogenesis, accompanied by a decrease in BMP and Hh signaling.
###end p 41
###begin title 42
Osteogenic differentiation of PF SMCs with Fulvestrant.
###end title 42
###begin p 43
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a</italic>
###xml 405 416 405 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteopontin</italic>
###xml 421 432 421 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin</italic>
###xml 503 513 503 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2, Bmp4</italic>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp7</italic>
###xml 577 591 577 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh, Ihh, Gli1</italic>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptc1</italic>
###xml 836 837 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Alkaline phosphatase staining with or without Fulvestrant after 7d differentiation. (B) Alizarin red staining with or without Fulvestrant after 14d differentiation. (C) Enzymatic alkaline phosphatase activity normalized to total protein content after 7d differentiation with or without Fulvestrant. (D, left) Runx2 and Col1a expression after 4d differentiation with or without Fulvestrant. (D, right) Osteopontin and Osteocalcin expression after 14d differentiation with or without Fulvestrant. (E) Bmp2, Bmp4, and Bmp7 expression after 4d with or without Fulvestrant. (F) Shh, Ihh, Gli1, and Ptc1 after 4d differentiation with or without Fulvestrant. Values are normalized and significance levels calculated relative to control groups in grey, photos are representative of random microscopical fields at 20x magnification, N = 3, *P<0.01.
###end p 43
###begin title 44
17-beta Estradiol increases chondrogenic differentiation of PF suture-derived mesenchymal cells
###end title 44
###begin p 45
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Nilsson1">[55]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Tanko1">[59]</xref>
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g001">Fig. 1E</xref>
###xml 563 572 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2B,D</xref>
###xml 650 658 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 697 703 693 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6</xref>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
Estrogen receptors are normally expressed in chondrocyte growth plates and have been shown to positively regulate chondrocyte maturation in various models [55]-[59]. Our previous observations had suggested that in the PF suture as well, estrogen signaling may play a role in chondrogenesis. For example, using immunohistochemistry we previously noted that ER protein expression was strongly present in chondrocytes within the PF suture, (see also Fig. 1E). In addition, the alphaERKO mouse demonstrated a complete lack of cartilage within the PF suture (see also Fig. 2B,D). Therefore, we next inquired as to the effects of estrogen signaling in the in vitro chondrogenic differentiation of SMCs (Fig. 6).
###end p 45
###begin title 46
Chondrogenic differentiation of PF SMCs with 17-beta Estradiol.
###end title 46
###begin p 47
###xml 6 13 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 18 24 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 57 65 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 190 194 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 274 280 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col II</italic>
###xml 324 333 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tgf-&#946;1</italic>
###xml 500 501 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A-B) ERalpha and ERbeta mRNA expression overtime during in vitro chondrogenic differentiation. Both transcripts were observed to increased overtime in culture after 6d differentiation. (C) Sox9 expression during chondrogenic differentiation with or without E2 (10 nM). (D) Col II expression with or without E2 (10 nM). (E) Tgf-beta1 expression with or without E2 (10 nm). Values are normalized and significance levels calculated relative to control groups or 0wk expression in grey or blue, N = 3, *P<0.01.
###end p 47
###begin p 48
###xml 9 16 9 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 21 27 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 103 110 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 210 222 203 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6A,B, N</xref>
###xml 229 230 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 384 388 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 432 438 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col II</italic>
###xml 459 471 452 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6C,D, N</xref>
###xml 478 479 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 545 549 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 554 560 547 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col II</italic>
###xml 610 622 603 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6C,D, N</xref>
###xml 629 631 622 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 692 696 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 701 707 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col II</italic>
###xml 752 764 745 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6C,D, N</xref>
###xml 771 772 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 883 891 876 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Firstly, ERalpha and ERbeta expression were evaluated over 9d chondrogenic differentiation by qRT-PCR. Results showed that gene expression of both estrogen receptors increased after 6d in chondrogenic medium, (Fig. 6A,B, N = 3, *P<0.01). We next added E2 to chondrogenic medium and examined gene markers of chondrogenic differentiation (10 nM). Expression of the transcription factor Sox9, as well as extracellular matrix component Col II were assessed, see (Fig. 6C,D, N = 3, *P<0.01). PF SMCs showed significantly increased expression of both Sox9 and Col II overtime under chondrogenic condition (grey bars Fig. 6C,D, N = 3, *P<0.01). Addition, however, of E2 significantly increased both Sox9 and Col II expression to a greater degree (yellow bars Fig. 6C,D, N = 3, #P<0.01). Thus, addition of E2 enhanced markers not only of osteo- but also chondrogenic differentiation of SMCs in vitro.
###end p 48
###begin p 49
###xml 70 78 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 83 90 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 90 93 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Xu1">[8]</xref>
###xml 95 99 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Dangelo1">[60]</xref>
###xml 101 105 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Maneix1">[61]</xref>
###xml 119 128 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tgf-&#946;1</italic>
###xml 186 193 180 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6E</xref>
###xml 208 217 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tgf-&#946;1</italic>
###xml 294 304 285 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6E, N</xref>
###xml 383 392 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tgf-&#946;1</italic>
###xml 405 412 393 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6E</xref>
TGF-beta1 induces chondrogenic differentiation of multiple cell types in vitro and in vivo[8], [60], [61]. We examined Tgf-beta1 gene expression upon E2 addition to chondrogenic medium (Fig. 6E). Without E2, Tgf-beta1 gene expression was observed to decreased overtime in chondrogenic culture (Fig. 6E, N = 3, *P<0.01). In contrast, E2 addition led to a significant up-regulation of Tgf-beta1 expression (Fig. 6E, **P<0.01). Thus, the pro-chondrogenic effect of E2 in PF SMCs may in part be due to maintained TGF-beta signaling.
###end p 49
###begin title 50
Fulvestrant inhibits calvarial osteogenesis in vivo
###end title 50
###begin p 51
###xml 229 236 225 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 437 444 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 551 555 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sibonga1">[62]</xref>
###xml 556 560 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lea1">[64]</xref>
###xml 713 724 709 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g007">Fig. 7A,C,E</xref>
###xml 883 894 879 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g007">Fig. 7B,D,F</xref>
###xml 1036 1045 1032 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g007">Fig. 7G&#8211;J</xref>
###xml 1471 1478 1467 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g007">Fig. 7Q</xref>
###xml 1973 1984 1969 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g007">Fig. 7K,L,Q</xref>
###xml 2022 2027 2018 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 2032 2052 2028 2048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sonic hedgehog (Shh)</italic>
###xml 2071 2078 2067 2074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 2094 2103 2090 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g007">Fig. 7M&#8211;P</xref>
###xml 2213 2218 2205 2210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 2223 2226 2215 2218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 2237 2242 2229 2234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 334 339 <span type="species:ncbi:10090">mouse</span>
Genetic knockout models suggested that estrogen signaling through ERalpha was necessary for normal PF suture fusion. We next inquired whether iatrogenic, biochemical perturbation of ER signaling could impede normal suture fusion in vivo. The biochemical antagonist Fulvestrant was applied subcutaneously, daily, to the midline of the mouse skull starting at p1 and applied for the following 10 days (10 ul of a 100 uM solution). Various in vivo applications of Fulvestrant have resulted in decreased bone volume accompanied by increased bone turnover [62]-[64]. Animals injected with vehicle control appeared grossly and histologically identical to non-manipulated animals and exhibited normal suture morphology (Fig. 7A,C,E). In marked contrast, those animals treated with Fulvestrant showed severely diminished calvarial osteogenesis, accompanied by widely patent sutures (N = 10, Fig. 7B,D,F). Cellular proliferation and cell death were examined in control and Fulvestrant treated calvariae by BrdU and TUNEL staining, respectively (Fig. 7G-J). A slight decrease in cellular proliferation was observed in treated as compared to control specimens. Positive TUNEL staining was sparsely observed in both control and treated specimens; most staining was observed among control specimens in those chondrocytes undergoing apoptosis within the fusing PF suture. Quantification of BrdU and TUNEL staining was performed using Adobe Photoshop, normalized to total cell number, (Fig. 7Q). This suggested that the phenotype observed with Fulvestrant treatment was not likely due to a direct change in either cellular proliferation or cell viability. We inquired as to whether Fulvestrant injection resulted in widespread osteoclastogenesis and concomitant bone turnover; this was assessed in treated and control calvariae by TRAP staining. Again, no differences were observed, suggesting that increased bone turnover could not explain the phenotype of Fulvestrant treated calvaria (Fig. 7K,L,Q). Finally, gene expression levels of Runx2 and Sonic hedgehog (Shh) were evaluated by in situ hybridization (Fig. 7M-P). As previously observed in the alphaERKO skull, Fulvestrant treatment resulted in diminished expression for Runx2 and Shh. Although Runx2 expression was not appreciably diminished, a slight difference in expression pattern was observed.
###end p 51
###begin title 52
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Fulvestrant application to mouse calvaria.
###end title 52
###begin p 53
###xml 1331 1344 1331 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2 in situ</italic>
###xml 1453 1464 1453 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh in situ</italic>
###xml 1824 1825 1824 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A-B) Control treated and Fulvestrant treated calvariae (N = 6, N = 10 respectively) (A) Dorsal view of p10 bone and cartilage preparation, showing normal calvarial morphogenesis in vehicle treated calvaria. (B) Overhead view of comparable Fulvestrant treated calvaria. A significant delay in mineralization was observed with widened sutures. (C) Pentachrome staining of p10 PF suture sectioned in a coronal plane. Normal developmental timing is observed, including progressive fusion and presence of a cartilage intermediate. (D) Comparable histological section of Fulvestrant treated a p10 PF suture, patency and diminished osteoid is apparent without cartilage. (E-F) Image of mid-frontal bone in control as compared to Fulvestrant treated calvaria, pentachrome stain. Severely diminished osteoid deposition (appearing yellow) is apparent among Fulvestrant treated calvaria. (G-H) BrdU incorporation in control in comparison to treated PF sutures. BrdU positive cells appear brown, while nuclei are counterstained with haemotoxylin. No significant difference was observed between control and Fulvestrant treated sutures (I-J) TUNEL staining in control and Fulvestrant treated PF sutures. Positive cells appear green. (K-L) TRAP staining in control and Fulvestrant treated PF sutures. Positively staining cells appear red. (M-N) Runx2 in situ hybridization in control and Fulvestrant treated PF sutures. Positively staining cells appear purple. (O-P) Shh in situ hybridization in control and Fulvestrant treated PF sutures. Positively staining cells appear purple. (Q) Quantitative assessments of percentage +BrdU, +TUNEL, or +TRAP stained cells, as calculated using Adobe Photoshop. For quantitative assessments, values are normalized and significance levels calculated relative to control treated groups shown in grey, *P<0.01.
###end p 53
###begin p 54
###xml 143 146 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sahar1">[4]</xref>
###xml 162 169 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 486 494 475 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 677 684 663 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
In summation, in this study we sought to correlate estrogen signaling with mouse cranial suture fusion, a process of endochondral ossification [4]. We found that ERalpha gene transcript abundance temporally coincides with PF suture fusion. Moreover, immunohistochemistry detected ER protein primarily within osteocytes and chondrocytes in cranial suture mesenchyme. Via analysis of ER knockout mice, functional ERalpha but not ERbeta was found to be necessary for normal suture fusion. In vitro cell culture of suture-derived mesenchymal cell (SMCs) suggested that 17-beta estradiol (E2) enhanced both osteogenic and chondrogenic differentiation within the PF suture. Finally, in vivo blockade of ER signaling in the developing calvaria via Fulvestrant inhibited suture fusion and led to severely diminished calvarial osteogenesis.
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-McCauley2">[22]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Chow1">[33]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Talwar1">[57]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Kharode1">[65]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Hernandez1">[66]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Smith1">[29]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Smith2">[31]</xref>
###xml 708 713 <span type="species:ncbi:10090">mouse</span>
Estrogens have been long considered of importance in bone and cartilage biology, as well as skeletal development, maturation and healing [22]. Therefore, natural and synthetic estrogens have been studied in basic osteochondroblast biology, as well as in clinical problems as bony non-union, osteoporosis, and osteoarthritis [33], [57], [65], [66]. In addition, functional estrogen signaling has been found to be necessary for developmental growth plate fusion [29]-[31]. This study addressed a related and straight-forward question: to what extent does estrogen signaling play a role in the development and fusion of cranial sutures? To study this, we chose an animal model of physiologic suture fusion: the mouse posterofrontal suture.
###end p 56
###begin p 57
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lin1">[12]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lin2">[13]</xref>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lin1">[12]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lin2">[13]</xref>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-vanderEerden1">[15]</xref>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-vanderEerden2">[16]</xref>
###xml 1193 1197 1193 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Parikka1">[26]</xref>
###xml 1199 1203 1199 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Chagin2">[27]</xref>
###xml 1773 1781 1769 1777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1504 1512 <span type="species:ncbi:9606">patients</span>
To date, we are only aware of one other group linking cranial suture biology with sex hormone signaling [12], [13]. Lin et al. in two publications examined androgen signaling in cranial sutures. They showed that androgen receptors are strongly expressed in fetal calvaria and dura mater, that cell culture with the male sex hormone dihydrotesterone (DHT) increased osteoblastic gene markers, and sagittal suture organ cultures aberrantly fused with DHT [12], [13]. As in our publication, they found similar patterns of receptor expression between male and female mice. Other groups have similarly noted comparable ER expression levels in bony tissue between the sexes [15], [16]. Our findings and others bring to the fore puzzling questions regarding the specificity of sex hormones in cranial suture biology. Firstly, despite the clear effects of hormone signaling on cranial suture fusion, how are sutures derived from male and female mice morphologically identical? Next, does genetic deficiency in sex hormone receptors affect both male and female derived sutures equivalently, or disparately? Interestingly, the severity of the appendicular skeletal phenotype of ERKO mice differs by sex [26], [27]; it remains unclear if these differences extend to the craniofacial skeleton. Our findings by quantitative RT-PCR, immunohistochemistry and cell culture, however, suggest that estrogens play a relevant role in suture developmental biology regardless of sex. Analogous findings are seen clinically as patients with either aromatase deficiency, ERalpha deficiency, or androgen insensitivity syndrome, have osteopenic skeletons, suggesting a need for both androgen and estrogen receptor signaling for maintenance of bone density. More detailed study however, particularly in vitro cell culture of male or female derived cells, is necessary to pursue these conjectures.
###end p 57
###begin p 58
###xml 153 160 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 169 175 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 225 231 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 920 927 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#945;</italic>
###xml 996 1002 954 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER&#946;</italic>
###xml 1015 1023 970 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s003">Fig. S3A</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
Our analysis of ERalpha and ERbeta gene expression and ERKO mice suggest that ER receptors are of unequal importance in cranial suture biology. Firstly, ERalpha but not ERbeta expression peaked during suture fusion. In fact, ERbeta expression demonstrated little change in either fusing (PF) or patent (SAG) sutures throughout early postnatal development. In addition, the PF suture of the alphaERKO mouse exhibited a delayed suture phenotype. Moreover, thorough analysis of the betaERKO mouse found normal suture morphogenesis, including normal developmental timing of PF suture fusion. Thus, these data suggest that ERalpha is of primary, and ERbeta secondary, importance in cranial suture biology. Other data support this hypothesis: we noted that ERalpha is expressed to a greater degree in the calvaria than ERbeta. In our hands, semi-quantitative PCR and Western blot both showed this to be true: robust bands for ERalpha expression were seen, while less intense bands were discernable for ERbeta expression (Fig. S3A,B).
###end p 58
###begin p 59
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
###xml 1061 1066 <span type="species:ncbi:10090">mouse</span>
We observed that application of the pan-ER antagonist Fulvestrant to the developing mouse calvaria resulted in a substantial decrease in cranial osteogenesis. While this iatrogenic defect mimicked the alphaERKO mouse suture phenotype, it was relatively more severe. How does one reconcile this difference in severity of phenotype produced by biochemical blockade versus genetic deficiency? TUNEL staining excluded cell death among Fulvestrant treated calvaria. One possibility is that ER genetic deficiency allows time for compensatory mechanisms to develop, allowing osteoblastic differentiation and mitigating the alphaERKO phenotype. In contrast, biochemical ER blockade via Fulvestrant injection represents a sub-acute insult to the developing skull, whereby no compensation can ensue. Another possibility is that intact signaling via ERbeta may partially mitigate the alphaERKO phenotype. Nevertheless, perturbation of ER signaling via both methods resulted in persistent PF suture patency, and indicated estrogen/ERalpha signaling as necessary for normal mouse suture fusion.
###end p 59
###begin p 60
###xml 287 295 273 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 407 412 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 417 421 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 427 435 413 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s003">Fig. S3C</xref>
###xml 764 772 739 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007120.s003">Fig. S3A</xref>
###xml 1096 1103 1061 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
###xml 999 1004 <span type="species:ncbi:10090">mouse</span>
In an effort to more fully delineate the importance of ERalpha vs ERbeta signaling, our laboratory has utilized synthetic estrogen agonists specific for either ERalpha or ERbeta in cell culture (propyl pyrazole triol, PPT, and diarylpropionitrile, DPN, respectively). Interestingly, our in vitro analysis suggests that both specific agonists up-regulate osteochondrogenic gene expression in SMCs (including Runx2 and Sox9, see Fig. S3C,D). How again does this reconcile with the apparent suture phenotype in the alphaERKO but not betaERKO mouse? From these data we speculate that estrogen/ERalpha signaling may be of principal importance in cranial suture biology owing to the comparative abundance of receptor expression in the developing cranial suture complex (Fig. S3A,B). Conversely, the relatively small expression level of ERbeta, as demonstrated on both gene and protein levels, may belie its importance. Moreover, ERbeta expression levels were observed to remain unchanged in the alphaERKO mouse, which argues against a functional compensation. More study utilizing specific ER agonists in vivo may further bring to light the relative importance of ERalpha and -beta.
###end p 60
###begin p 61
###xml 257 260 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Xu1">[8]</xref>
###xml 262 266 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Warren1">[10]</xref>
###xml 268 272 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Bradley1">[67]</xref>
###xml 274 278 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Greenwald2">[68]</xref>
###xml 428 431 425 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Lenton1">[3]</xref>
###xml 836 840 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Vanderschueren1">[69]</xref>
###xml 842 846 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Westerlind1">[70]</xref>
###xml 1264 1268 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-IgnarTrowbridge1">[71]</xref>
###xml 1269 1273 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Klotz1">[73]</xref>
Most studies in the field of cranial suture biology have stressed the relative importance of dura mater in determining fate and timing of suture development. This includes locoregional production of FGF-2, TGF-beta1, the BMP antagonist Noggin, among others [8], [10], [67], [68]. These paracrine factors are hypothesized to work locally on the overlying suture mesenchyme, promoting differentiation and ultimately suture fusion [3]. In this conceptual, regulatory framework, how might an endocrine hormone influence suture fusion? Our study has identified estrogen responsive cells by localizing ER expression patterns, but does not indicate a source for estrogen ligands, whether it be locoregional or distant. Studies in long bones, however, suggest that production of estrogens by adjacent periosteum affects growth plate maturation [69], [70]. We speculate that dura mater, a known source of paracrine factors integral to suture fusion, may analogously be a source of regional estrogen production. More study is needed to probe this conjecture. Alternatively, those peptide growth factors known to be localized to PF-associated dura mater (including TGF-beta and IGF-1) have been shown to exert transcriptional effects in an estrogen receptor-dependent manner [71]-[73]. Thus, known local paracrine factors may exert cellular and morphologic effects on the overlying suture in an ER-dependent manner, either in the absence or in synergism with E2.
###end p 61
###begin p 62
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 375 383 375 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 419 426 419 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4F</xref>
###xml 575 582 575 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4G</xref>
###xml 615 623 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tgf&#946;1</italic>
###xml 658 665 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g006">Fig. 6E</xref>
###xml 772 775 766 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Xu1">[8]</xref>
###xml 777 781 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Warren1">[10]</xref>
###xml 783 787 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Opperman1">[11]</xref>
###xml 789 793 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Mehrara1">[74]</xref>
###xml 806 814 800 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 970 974 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-IgnarTrowbridge2">[72]</xref>
###xml 976 980 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Klotz1">[73]</xref>
###xml 982 986 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Zofkova1">[75]</xref>
###xml 988 992 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Giustina1">[76]</xref>
###xml 1064 1068 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Roth1">[77]</xref>
###xml 1069 1073 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Bradley2">[79]</xref>
###xml 1185 1193 1179 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1217 1224 1211 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Despite the as yet unclear mechanism whereby E2 may selectively be involved in PF suture fusion, our in vitro studies in suture-derived mesenchymal cells (SMCs) suggest a transcriptional relationship between E2 and other cytokines known to play a role in suture biology. For example, transcription of a number of pro-osteogenic BMPs was positively regulated by E2 in PF SMCs in vitro during osteogenic differentiation (Fig. 4F). Moreover, both Sonic and Indian Hedgehog, known important players in osteoblast and chondrocyte differentiation, were up-regulated by E2 as well (Fig. 4G). In addition, transcription of Tgfbeta1 was increased with E2 in PF SMCs (Fig. 6E). Both BMP and TGF-beta signaling are associated with and necessary for physiologic cranial suture fusion [8], [10], [11], [74], and in our in vitro model system were positively regulated by E2. Moreover, abundant data in the literature suggest a positive intersection between estrogen and IGF signaling [72], [73], [75], [76], another peptide molecule of known importance in cranial suture fusion [77]-[79]. We explored this possibility, however E2 was not observed to significantly effect IGF gene expression in SMCs in vitro (data not shown). More in vivo correlates must be sought, but these data potentially implicate estrogen signaling in a cascade of known molecular mediators in cranial suture fusion.
###end p 62
###begin p 63
###xml 282 291 274 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g002">Fig. 2G,H</xref>
###xml 378 386 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 388 394 380 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g004">Fig. 4</xref>
###xml 395 396 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007120-g005">5</xref>
###xml 562 566 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-StJacques1">[50]</xref>
###xml 769 773 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-StJacques1">[50]</xref>
###xml 850 854 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Koga1">[51]</xref>
###xml 856 860 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Hewitt1">[80]</xref>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
Especially pertinent to our discussion is the possible relationship between E2/ERalpha signaling and Hedgehog (Hh) signaling in cranial sutures. Interestingly, while the WT posterofrontal cranial suture shows abundant staining for hedgehog ligands, the alphaERKO PF suture did not (Fig. 2G,H). Moreover, Hedgehog signaling was dynamically regulated by E2 or Fulvestrant in SMCs in vitro (Fig. 4,5). It is known that mice with genetic deficiency in Ihh have severe skeletal defects, including severely shortened limbs due to a defect in endochondral ossification [50]. Moreover, the Ihh null mouse has a cranial suture phenotype with reduced calvarial bone size, a phenotype which may have similarities to the alphaERKO calvaria, although this has not been well studied [50]. Hedgehog signaling has been shown to be up-regulated by estrogen signaling [51], [80]. To our knowledge, this is the first publication in which estrogen signaling has been shown to positively regulate Hedgehog signaling in bone-forming cells of any type. Moreover, preliminary data from our laboratory suggests that increased Hedgehog signaling (via the addition of N-terminal Sonic Hedgehog to osteogenic medium) significantly enhances the osteogenic differentiation of SMCs in a similar fashion to E2 (data not shown). The potential cooperative relationship between E2 and Hh signaling will be the topic of future research.
###end p 63
###begin p 64
###xml 297 300 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sahar1">[4]</xref>
###xml 302 305 302 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Manzanares1">[5]</xref>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 503 508 <span type="species:ncbi:10090">mouse</span>
###xml 753 758 <span type="species:ncbi:9606">human</span>
Important limitations to this study exist toward the extrapolation to the clinical entity of craniosynotosis. The posterofrontal suture is an example of physiologic suture fusion, and thus has parallels to the human metopic suture, in both, there exists a cartilage intermediate preceding closure [4], [5]. However, chondrogenesis has not been shown to precede clinical craniosynostosis, whether syndromic or sporadic. Moreover, a cartilaginous intermediate does not develop in any other sutures of the mouse skull. Therefore, while this study has immediate applicability to normal calvarial skeletogenesis and programmed suture fusion, the relevance of these data to clinical, pathologic suture fusion remains as yet unclear. ER expression patterns in human synostotic sutures may yield fruitful insight into the possible connection between pathologic suture fusion and estrogen signaling.
###end p 64
###begin p 65
###xml 221 226 <span type="species:ncbi:10090">mouse</span>
In conclusion, the role of estrogen signaling is of newly recognized importance in suture biology. ER gene expression is associated with physiologic cranial suture fusion. Intact ERalpha signaling is necessary for normal mouse cranial suture fusion. Finally, culture of PF suture-derived cells suggests that estrogen signaling may positively regulate both osteoblast and chondrocyte differentiation within the suture complex.
###end p 65
###begin title 66
Materials and Methods
###end title 66
###begin title 67
Chemicals, supplies and animals
###end title 67
###begin p 68
###xml 167 173 <span type="species:ncbi:9913">bovine</span>
Phenol red-free Dulbecco's Modified Eagles Medium (DMEM) and phenol red-free penicillin/streptomycin were purchased from GIBCO Life Technologies (Carlsbad, CA). Fetal bovine serum (FBS) was purchased from Omega Scientific (Tarzana, CA). All cell culture supplies were purchased from Corning Inc. (San Mateo, CA). RNAeasy kits were purchased from Qiagen Sciences (Valenica, CA), while other RNA reagents were purchased from Applied Biosystems, (Foster City, CA). Unless otherwise specified, all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
###end p 68
###begin p 69
###xml 344 348 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Emmen1">[81]</xref>
###xml 432 442 425 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
All experiments followed protocols approved by the Animal Facilities of Stanford University and the NIEHS/NIH. CD-1 mice were purchased from Charles Rivers Laboratories (Wilmington, MA). Male alphaERKO and betaERKO mice on a C57BL/6J background and wild-type littermates were provided from the NIEHS, and were genotyped as previously described [81]. Animals were housed in a light and temperature controlled facility and given food ad libitum. For all experiments, the first day of life was considered the first day after birth.
###end p 69
###begin title 70
Whole mount bone and cartilage preparations
###end title 70
###begin p 71
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Whole calvariae denuded of skin were fixed overnight in 100% ethanol (postnatal days 4-19, N = 3-5 per time point from both male and female mice). Calvariae were then stained with an Alcian blue solution in 30% acetic acid/70% ethanol to visualize cartilage. Samples were then washed in 0.5% potassium hydroxide, stained with an 0.01% Alizarin Red S solution in 0.5% potassium hydroxide to visualize mineralized bone, washed in PBS, and cleared in a series of graded glycerol. Pictures were taken at 1x-1.6x magnification utilizing the Leica digital imaging system; specimens were stored at room temperature.
###end p 71
###begin title 72
Preparation of tissues for histology
###end title 72
###begin p 73
###xml 200 204 <span type="species:ncbi:10090">mice</span>
Whole calvariae denuded of skin were fixed overnight in 0.4% paraformaldehyde in PBS at 4degreesC (postnatal days 4-30, N = 2-3 per time point). Tissue was taken from equal numbers of male and female mice. PF and SAG sutures with flanking calvarial bones were dissected, tissue was decalcified in 19% ethylenediaminetetracetic acid for 2-14 days at 4degreesC, dehydrated through graded ethanol, and paraffin embedded. Coronal sections through PF and SAG sutures of 5 micron width were mounted on Superfrost plus slides (Fisher Scientific, Pittsburg, PA), and dried overnight at 37degreesC. Approximately 200 sections were obtained from each skull; slides were stored at room temperature.
###end p 73
###begin title 74
Histological staining and immunohistochemistry
###end title 74
###begin p 75
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 503 508 <span type="species:ncbi:10090">mouse</span>
Every 5th slide of PF and SAG sutures were stained with routine haematoxylin and eosin. Select slides were stained with pentachrome stain to visualize both bone and cartilage, which appear yellow and blue/green, respectively. Cellular proliferation was assessed by bromodeoxyuridine (BrdU) and PCNA immunohistochemical staining according to the manufacturer's instructions (Zymed, South San Francisco, CA). A haematoxylin counterstain was employed. BrdU labeling reagent was administered 2 hrs prior to mouse sacrifice. Cell death was examined by an in situ cell death detection kit per the manufacturer's instructions (Roche Applied Science, Indianapolis, IN). A DAPI counterstain was employed. Bone turnover was assayed by tartrate resistant acid phosphatase staining (TRAP staining) according to the manufacturer's recommendations.
###end p 75
###begin p 76
###xml 231 235 <span type="species:ncbi:9925">goat</span>
###xml 275 281 <span type="species:ncbi:9986">rabbit</span>
###xml 371 377 <span type="species:ncbi:9986">rabbit</span>
###xml 467 473 <span type="species:ncbi:9986">rabbit</span>
###xml 1103 1107 <span type="species:ncbi:10090">mice</span>
Immunohistochemistry was performed on select slides for ERalpha and ERbeta. Slides were deparaffinized and rehydrated. Endogenous peroxidase activity was quenched with 3% hydrogen peroxide in methanol; slides were blocked with 10% goat serum in PBS. Antibodies used included rabbit polyclonal anti-ERalpha, (1:80 in dilution, Santa Cruz Laboratories, Santa Cruz, CA), or rabbit polyclonal anti-ERbeta (1:2 dilution, BioGenex, San Ramon, CA), and were suspended in 1% rabbit serum. Appropriate biotinylated secondary antibodies were used in 1:1000 dilution (Vector Laboratories, Burlingame, CA). The Vectastain ABC system (Vector Laboratories, Burlingame, CA) was used according to the manufacturer's instructions. Visualization was with diaminobenzidine solution (Zymed Laboratories, South San Francisco, CA). Slides without primary antibody were used as a negative control. No less than 5 slides were stained for each antibody, per time point. To account for possible gender variability, for each time point immunohistochemistry was performed on equal numbers of slides taken from both male and female mice. Representative photographs were taken at 20x-40x magnification (Zeiss Axioplan, Thornwood, NY).
###end p 76
###begin p 77
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 26 36 26 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2, Ihh</italic>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shh</italic>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Albrecht1">[82]</xref>
###xml 333 338 <span type="species:ncbi:9940">sheep</span>
In situ hybridization for Runx2, Ihh and Shh was performed as previously described [82]. Antisense riboprobe was transcribed in the presence of Dig-11-UTP (Roche). Sections were incubated for 65degreesC for 12 hrs in hybridization buffer (Ambion, Austin TX) containing riboprobe at approximately1 ug/mL. Slides were blocked with 10% sheep serum, 2% Boehringer-Mannheim Blocking Reagent (Roche) and levamisole, and developed using NBT and BCIP for color.
###end p 77
###begin p 78
To assess quantitative differences in staining, Adobe photoshop was utilized. Pixel number of positively stained cells for BrdU, TUNEL, TRAP or Shh were quantified from 5 random high-powered fields using the magic want tool. Values were divided by the pixel number of DAPI staining in the same images. Means and standard deviations were calculated.
###end p 78
###begin title 79
Quantitative Assesment of Suture Fusion
###end title 79
###begin p 80
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Mehrara1">[74]</xref>
To assess degree of suture fusion, the entirety of each suture was sectioned. Every 5th section was stained with H&E (equivalent to one section per 25 microns), and was evaluated by two independent observers. Fusion was defined as bony bridging between osteogenic fronts of the suture, and was considered a binary variable (1 = fusion, 0 = patent). In the case of interobserver disagreement, a third party made the determination. To calculate percentage fusion, the number of individual slides showing a fused suture was divided by the total number of stained slides. This method was taken with adaptation from our previous publication [74].
###end p 80
###begin title 81
Quantification of gene expression in cranial sutures in vivo
###end title 81
###begin p 82
###xml 661 664 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Sahar1">[4]</xref>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">free</italic>
###xml 1087 1092 1085 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Power</italic>
###xml 1321 1328 1319 1326 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1321 1328 1319 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007120-t001"><bold>Table 1</bold></xref>
###xml 1493 1498 1491 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
Total ribonucleic acid (RNA) was isolated from PF and SAG suture complexes at stratified postnatal time points (postnatal days 4, 7, 10, 13, 16, 19 - points preceding, during, and after fusion of the PF suture; N = 10 per time point of mixed gender). Calvariae were dissected in cold, sterile phosphate-buffered saline (PBS). Pericranium was meticulously removed with fine-tipped forceps under a dissecting microscope (Dumont #55 Forceps, Fine Science Tools, Foster City, CA). PF and SAG sutures were then isolated with 500 micron bony margins on either side as well as underlying dura mater; dissections were based on previously established anatomic landmarks [4]. Sutures from each time point were pooled, snap-frozen in liquid nitrogen, homogenized with a pestle, and purified using the RNeasy Mini Kit. DNase treatment was performed with the DNA-free kit according to the manufacturer's instructions (Ambion, Austin, TX). One ug RNA was reverse transcribed using TaqMAN(R) Reverse Transcription Reagents. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed with Power Sybr green detection on a 7900HT Sequence Detection System according to the manufacturer's instructions. Specific primers for the genes examined were designed based on their PrimerBank sequence (). Primer sequences are shown in Table 1. PCR products were first run on a 2% agarose gel to confirm the appropriate size and specificity. Levels of gene expression were determined by normalizing to their GAPDH values. All reactions were performed in triplicate.
###end p 82
###begin title 83
Quantitative PCR Genes and Primer Sequences.
###end title 83
###begin title 84
Protein quantification in whole calvariae in vivo
###end title 84
###begin p 85
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 806 817 <span type="species:ncbi:3704">horseradish</span>
Protein was isolated from the whole calvaria of p10 mouse skulls after meticulous dissection of pericranium, dura mater and ligamentous attachments. 40 ug of total protein extracted with radioimmunoprecipitation assay (RIPA) buffer (containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5% Glycerol, 1 mM EDTA, 1% NP-40, 0.1% SDS and 0.25% Na-deoxycholate) was separated on 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to polyvinylidene fluoride membranes, and blocked with 5% milk/Tris-buffered saline-T for 2 hours. Protein detection was performed with primary antibodies against ERalpha (1:1000 dilution), ERbeta, and beta-actin (1:5000 dilution; Lab Vision, Fremont, CA) in 5% milk/Tris-buffered saline-T overnight at 4degreesC. Blots were then incubated with the corresponding horseradish peroxidase-linked secondary antibodies (1:10,000 dilution; BD Pharmingen, San Jose, CA) for 1 hr at room temperature. Blots were developed with ECL detection reagent (Amersham, United Kingdom) and exposed for 1 to 10 minutes using Biomax-MS film (Eastman Kodak, Rochester, NY).
###end p 85
###begin title 86
Tissue harvest and primary cell culture
###end title 86
###begin p 87
###xml 8 16 8 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 182 185 182 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James1">[7]</xref>
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Xu1">[8]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James2">[32]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Xu2">[83]</xref>
###xml 613 614 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
For all in vitro experiments, PF suture-derived mesenchymal cells (SMCs) were harvested from 200 four-day-old CD1 mice via non-enzymatic primary cell harvest as previously described [7], [8], [32], [83]. PF sutures were dissected with 500 um bony margins, meticulously stripped of all pericranial and dural tissues, and plated in 100-mm tissue culture dishes (endocranial surface was placed flush to the culture dish, approximately 10 sutures per plate). Explants were cultured in growth medium containing DMEM, 10% FBS, 100 IU/ml of penicillin/streptomycin, and maintained at 37degreesC in an atmosphere of 5% CO2. Phenol red-free culture medium was used in all assays to avoid its estrogenic effects. Over seven days in culture, SMCs were allowed to migrate from suture explants; cellular yield was approximately 100,000 cells per suture explant. SMCs were passaged by trypsinization; passage one SMCs only were used for all experiments.
###end p 87
###begin title 88
Cellular proliferation assays
###end title 88
###begin p 89
###xml 146 150 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James2">[32]</xref>
###xml 351 357 <span type="species:ncbi:9913">bovine</span>
The growth of SMCs in response to 17-beta estradiol (E2) or Fulvestrant was compared by BrdU incorporation assays as previously described (N = 6) [32]. Cells were seeded in 96-well plates at a density of 1,000 cells/well and were treated with growth medium supplemented with E2 (0.1-100 nM), Fulvestrant (0.1-10 uM), or vehicle as a control (10 ug/ml bovine serum albumin or 0.1% dimethyl sulfoxide, respectively). At 3d and 6d growth, BrdU incorporation assays were performed according to the manufacturer's instruction (Roche Applied Science, Indianapolis, IN). Labeling with BrdU was performed for a period of 8 hrs. Means and standard deviations were calculated.
###end p 89
###begin title 90
Osteogenic differentiation and assessments
###end title 90
###begin p 91
###xml 275 279 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James2">[32]</xref>
Cells were plated in 24-well plates at a density of 10,000 cells/well, and were treated with osteogenic differentiation medium (ODM) containing DMEM, 10% FBS, 100 microg/ml ascorbic acid, 10 mM beta-glycerophosphate, 100 IU/ml penicillin/streptomycin as previously described [32]. ODM was supplemented with E2 (1-100 nM), Fulvestrant (0.1-10 uM), the ERalpha specific agonist propyl pyrazole triol (PPT, 1-100 nM), ERbeta specific agonist diarylpropionitrile (DPN, 1-100 nM), or with vehicle as a control (Sigma-Aldrich, St. Louis, MO).
###end p 91
###begin p 92
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James2">[32]</xref>
###xml 505 506 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To assess early osteogenic differentiation, alkaline phosphatase (ALP) staining and quantification was performed after 7d differentiation as previously described [32]. For staining, cells were fixed with a 60% acetone, 40% citrate solution, and stained with a diazonium salt with 4% napthol AS-MX phosphate alkaline solution. Alkaline phosphatase positive cells were stained purple. For ALP quantification, protein was isolated in RIPA buffer. The alkaline phosphate activity was assayed by measuring the p-nitrophenol formed from the enzymatic hydrolysis of p-nitrophenylphosphate. Experiments were performed in triplicate wells; means and standard deviations were calculated.
###end p 92
###begin p 93
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James2">[32]</xref>
After 14d osteogenic differentiation, Alizarin red S staining was performed to detect extracellular mineralization as previously described [32]. Briefly, cells were fixed in 100% ethanol and stained with a 0.2% Alizarin red S solution. The red staining represents calcium deposits on differentiated cells.
###end p 93
###begin p 94
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 185 206 185 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Alkaline phosphatase</italic>
###xml 208 241 208 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Collagen Type 1&#945;, Osteopontin</italic>
###xml 243 394 239 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Osteocalcin, Bone morphogenetic protein-2, -4, -7, Sonic Hedgehog, Indian Hedgehog, Gli1, Ptc1, Sex determining region Y-box 9 (Sox9), ER&#945;, ER&#946;)</italic>
Finally, total RNA was isolated from SMCs at 2, 4, 7, and 14d of osteogenic differentiation. Gene expression of the transcription factor Runx2, as well as other markers of osteogenesis (Alkaline phosphatase, Collagen Type 1alpha, Osteopontin, Osteocalcin, Bone morphogenetic protein-2, -4, -7, Sonic Hedgehog, Indian Hedgehog, Gli1, Ptc1, Sex determining region Y-box 9 (Sox9), ERalpha, ERbeta) was evaluated by quantitative RT-PCR.
###end p 94
###begin title 95
Chondrogenic differentiation and assessments
###end title 95
###begin p 96
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-James1">[7]</xref>
###xml 313 316 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007120-Xu1">[8]</xref>
###xml 555 607 555 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Sox9, Collagen Type II, TGF-&#946;1, ER&#945;, ER&#946;)</italic>
###xml 640 647 630 637 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 640 647 630 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007120-t001"><bold>Table 1</bold></xref>
Cells were plated in 12-well plates at a high density of 70,000 cells/well; SMCs were treated with chondrogenic differentiation medium containing DMEM, 1% FBS, 37.5 ug/ml ascorbate-2-phophate, ITS premix (BD Biosciences, Franklin Lakes, NJ), and 100 IU/ml penicillin and streptomycin as previously described [7], [8]. E2 (10 nM) or vehicle as a control was supplemented to chondrogenic medium. Medium was supplemented every three days. At 3, 6, and 9d of differentiation, RNA was isolated and gene markers of chondrogenesis were examined by real-time PCR (Sox9, Collagen Type II, TGF-beta1, ERalpha, ERbeta). Primer sequences are listed in Table 1.
###end p 96
###begin title 97
In vivo Fulvestrant application and assessments
###end title 97
###begin p 98
###xml 122 129 122 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
To test the necessity of estrogen signaling in the suture fusion, the synthetic pan-ER antagonist Fulvestrant was applied in vivo. Starting at birth, 10 ul of a 100 uM solution Fulvestrant (in a suspension containing 0.9% normal saline, 0.01% DMSO) was injected subcutaneously, daily, directly overlying the midline sutures. Vehicle (0.9% normal saline, 0.01% DMSO) was injected in littermates as a control. Skulls were harvested at p10 for analysis by whole mount bone and cartilage preparations, as well as serial coronal sections for histology.
###end p 98
###begin title 99
Statistical analysis
###end title 99
###begin p 100
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 440 444 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#8804;</italic>
Means and standard deviations were calculated from numerical data, as presented in the text, figures, and figure legends. In graphs, columns represent means whereas error bars represent one standard deviation. Statistical analysis was performed using the ANOVA two-factor with replication when more than two factors were compared. In supplement, the Welch's two-tailed t-test was used when standard deviations between groups were unequal. *P</=0.01 was considered to be significant.
###end p 100
###begin title 101
Supporting Information
###end title 101
###begin p 102
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Gross morphology of PF and SAG sutures. Whole mount bone (red) and cartilage (blue) preparations of mouse calvaraie, ages postnatal day (p)4 through 19. The posterofrontal (PF) suture lies anterior (above in this orientation), while the sagittal (SAG) suture lies posterior (below). (A) At p4, both PF and SAG sutures are widely separated. (B-E) Islands of bony bridging are observed within the PF suture (p7-16). (F) By p19 (bottom right), the PF suture is largely fused. Note that tongues of cartilage (stained blue) are observed in the early postnatal skull base (p4, p7). Degree of red hue generally represents thickness of mineralized bone, with the exception of the area of the coronal (COR) suture, where this represents overlap of one calvarial bone on another; photographs are taken at 1.6x magnification.
###end p 102
###begin p 103
(3.44 MB TIF)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
Histological morphology of PF and SAG sutures. Pentachrome staining of coronal sections through PF and SAG sutures, p4-p19. Osteoid appears yellow, while glycosaminoglycan in cartilage appear blue/green. In the PF suture (first and third columns), a cartilaginous intermediate is apparent from p7 to p13 located on the endocranial aspect of the suture (C-F,M,N). From p16 onwards, osseous fusion of the PF suture can be observed (O-R). In contrast, an undifferentiated cellular mesenchyme is observed at all time points in the SAG suture with maintenance of suture patency, (second and fourth columns). Photographs are taken from the anterior aspect of PF and SAG sutures, and are at 20x and 40x magnification.
###end p 105
###begin p 106
(7.50 MB TIF)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
###xml 583 590 555 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 271 276 <span type="species:ncbi:10090">mouse</span>
###xml 342 347 <span type="species:ncbi:10090">mouse</span>
Comparison of Estrogen Receptor Expression and Stimulation (A) Expression of ERalpha and ERbeta within the p10 mouse skull by semi-quantitative PCR at 30 cycles. ERalpha is expressed to a greater degree than is ERbeta. (B) Expression of ERalpha and ERbeta within the p10 mouse skull by western blot. Experiments were performed in triplicate; mouse uterine tissue was used as a positive control. (B-C) PF SMCs were cultured with or without the ER specific agonists PPT or DPN (ERalpha and ERbeta specific agonists, respectively). Runx2 and Sox9 expression was evaluated after 48 hrs. Results showed that both PPT and DPN significantly and dose-dependently increased Runx2 and Sox9 expression in PF SMCs. No difference was observed between ERalpha and ERbeta specific agonists. Values are normalized and significance levels calculated relative to control groups, N = 3, *P<0.01.
###end p 108
###begin p 109
(5.17 MB TIF)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin p 111
We thank L. MacLeod and M.G. Galvez for their excellent technical assistance.
###end p 111
###begin title 112
References
###end title 112
###begin article-title 113
Comparison of anthropometric and cephalometric measurements of the adult face.
###end article-title 113
###begin article-title 114
Management of craniosynostosis.
###end article-title 114
###begin article-title 115
Cranial suture biology.
###end article-title 115
###begin article-title 116
Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture.
###end article-title 116
###begin article-title 117
###xml 31 36 <span type="species:ncbi:9606">human</span>
Metopic sutural closure in the human skull.
###end article-title 117
###begin article-title 118
The Biology of Sutures.
###end article-title 118
###begin article-title 119
Differential effects of TGF-beta1 and TGF-beta3 on chondrogenesis in posterofrontal cranial suture-derived mesenchymal cells in vitro.
###end article-title 119
###begin article-title 120
Transforming Growth Factor-beta1 Stimulates Chondrogenic Differentiation of Posterofrontal Suture-Derived Mesenchymal Cells In Vitro.
###end article-title 120
###begin article-title 121
In vivo modulation of FGF biological activity alters cranial suture fate.
###end article-title 121
###begin article-title 122
The BMP antagonist noggin regulates cranial suture fusion.
###end article-title 122
###begin article-title 123
TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro.
###end article-title 123
###begin article-title 124
Immunolocalization of androgen receptor in the developing craniofacial skeleton.
###end article-title 124
###begin article-title 125
Dihydrotestosterone stimulates proliferation and differentiation of fetal calvarial osteoblasts and dural cells and induces cranial suture fusion.
###end article-title 125
###begin article-title 126
Estrogen receptors in skeletal metabolism: lessons from genetically modified models of receptor function.
###end article-title 126
###begin article-title 127
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Expression of estrogen receptor alpha and beta in the epiphyseal plate of the rat.
###end article-title 127
###begin article-title 128
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Expression of estrogen receptors and enzymes involved in sex steroid metabolism in the rat tibia during sexual maturation.
###end article-title 128
###begin article-title 129
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Morphological alterations in the growth plate cartilage of ovariectomized mice.
###end article-title 129
###begin article-title 130
###xml 70 75 <span type="species:ncbi:9606">human</span>
Estrogen receptor-alpha and estrogen receptor-beta are present in the human growth plate in childhood and adolescence, in identical distribution.
###end article-title 130
###begin article-title 131
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis.
###end article-title 131
###begin article-title 132
Estrogen, bone, growth and sex: a sea change in conventional wisdom.
###end article-title 132
###begin article-title 133
Mutations in the synthesis and action of estrogen: the critical role in the male of estrogen on pubertal growth, skeletal maturation, and bone mass.
###end article-title 133
###begin article-title 134
Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism.
###end article-title 134
###begin article-title 135
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Estrogen receptor specificity in the regulation of the skeleton in female mice.
###end article-title 135
###begin article-title 136
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice.
###end article-title 136
###begin article-title 137
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Disproportional body growth in female estrogen receptor-alpha-inactivated mice.
###end article-title 137
###begin article-title 138
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice.
###end article-title 138
###begin article-title 139
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice.
###end article-title 139
###begin article-title 140
Oestrogen receptors and linear bone growth.
###end article-title 140
###begin article-title 141
###xml 76 79 <span type="species:ncbi:9606">man</span>
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.
###end article-title 141
###begin article-title 142
###xml 42 45 <span type="species:ncbi:9606">man</span>
Effect of testosterone and estradiol in a man with aromatase deficiency.
###end article-title 142
###begin article-title 143
Impact on bone of an estrogen receptor-alpha gene loss of function mutation.
###end article-title 143
###begin article-title 144
Proliferation, osteogenic differentiation, and fgf-2 modulation of posterofrontal/sagittal suture-derived mesenchymal cells in vitro.
###end article-title 144
###begin article-title 145
###xml 65 69 <span type="species:ncbi:10116">rats</span>
17 beta-estradiol stimulates cancellous bone formation in female rats.
###end article-title 145
###begin article-title 146
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Estrogen-induced osteogenesis in mice is associated with the appearance of Cbfa1-expressing bone marrow cells.
###end article-title 146
###begin article-title 147
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice.
###end article-title 147
###begin article-title 148
17Beta-estradiol stimulates mineralized bone nodule formation when added intermittently to SaOS-2 cells.
###end article-title 148
###begin article-title 149
###xml 82 87 <span type="species:ncbi:9606">human</span>
Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells.
###end article-title 149
###begin article-title 150
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
###end article-title 150
###begin article-title 151
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta.
###end article-title 151
###begin article-title 152
###xml 88 93 <span type="species:ncbi:9606">human</span>
Up-regulation of estrogen receptor-beta expression during osteogenic differentiation of human periodontal ligament cells.
###end article-title 152
###begin article-title 153
Bone morphogenetic proteins.
###end article-title 153
###begin article-title 154
Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor.
###end article-title 154
###begin article-title 155
Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
###end article-title 155
###begin article-title 156
Transcriptional regulation of a BMP-6 promoter by estrogen receptor alpha.
###end article-title 156
###begin article-title 157
Cross-talk between bone morphogenic proteins and estrogen receptor signaling.
###end article-title 157
###begin article-title 158
Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells.
###end article-title 158
###begin article-title 159
Hedgehog promotes primary osteoblast differentiation and increases PTHrP mRNA expression and iPTHrP secretion.
###end article-title 159
###begin article-title 160
Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2.
###end article-title 160
###begin article-title 161
Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation.
###end article-title 161
###begin article-title 162
Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation.
###end article-title 162
###begin article-title 163
Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer.
###end article-title 163
###begin article-title 164
###xml 59 64 <span type="species:ncbi:9606">human</span>
Downregulation of beta-catenin and transdifferentiation of human osteoblasts to adipocytes under estrogen deficiency.
###end article-title 164
###begin article-title 165
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Comparative effects of estrogen and antiestrogens on differentiation of osteoblasts in mouse bone marrow culture.
###end article-title 165
###begin article-title 166
###xml 81 86 <span type="species:ncbi:9606">human</span>
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.
###end article-title 166
###begin article-title 167
Endocrine regulation of the growth plate.
###end article-title 167
###begin article-title 168
###xml 88 91 <span type="species:ncbi:10116">rat</span>
###xml 96 102 <span type="species:ncbi:9986">rabbit</span>
Estrogen receptor-alpha and -beta are expressed throughout postnatal development in the rat and rabbit growth plate.
###end article-title 168
###begin article-title 169
Effects of estrogen on chondrocyte proliferation and collagen synthesis in skeletally mature articular cartilage.
###end article-title 169
###begin article-title 170
Growth and differentiation factors for cartilage healing and repair.
###end article-title 170
###begin article-title 171
An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage.
###end article-title 171
###begin article-title 172
Activation of transforming growth factor beta in chondrocytes undergoing endochondral ossification.
###end article-title 172
###begin article-title 173
17Beta-oestradiol up-regulates the expression of a functional UDP-glucose dehydrogenase in articular chondrocytes: comparison with effects of cytokines and growth factors.
###end article-title 173
###begin article-title 174
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia.
###end article-title 174
###begin article-title 175
###xml 77 81 <span type="species:ncbi:10116">rats</span>
The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats.
###end article-title 175
###begin article-title 176
###xml 47 51 <span type="species:ncbi:10116">rats</span>
Ovarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780.
###end article-title 176
###begin article-title 177
###xml 30 33 <span type="species:ncbi:10116">rat</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery.
###end article-title 177
###begin article-title 178
Aromatase expression in osteoarthritic and osteoporotic bone.
###end article-title 178
###begin article-title 179
Studies in cranial suture biology: regional dura mater determines in vitro cranial suture fusion.
###end article-title 179
###begin article-title 180
Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.
###end article-title 180
###begin article-title 181
Clinical Review: Sex steroids and the periosteum-reconsidering the roles of androgens and estrogens in periosteal expansion.
###end article-title 181
###begin article-title 182
###xml 47 50 <span type="species:ncbi:10116">rat</span>
Estrogen receptor mRNA is expressed in vivo in rat calvarial periosteum.
###end article-title 182
###begin article-title 183
Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
###end article-title 183
###begin article-title 184
Cross talk between peptide growth factor and estrogen receptor signaling systems.
###end article-title 184
###begin article-title 185
Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
###end article-title 185
###begin article-title 186
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion.
###end article-title 186
###begin article-title 187
Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.
###end article-title 187
###begin article-title 188
Growth hormone, insulin-like growth factors, and the skeleton.
###end article-title 188
###begin article-title 189
Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion.
###end article-title 189
###begin article-title 190
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Effect of tensile force on the expression of IGF-I and IGF-I receptor in the organ-cultured rat cranial suture.
###end article-title 190
###begin article-title 191
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Increased IGF-I and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion.
###end article-title 191
###begin article-title 192
Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen.
###end article-title 192
###begin article-title 193
###xml 107 111 <span type="species:ncbi:10090">mice</span>
In vitro growth and ovulation of follicles from ovaries of estrogen receptor (ER){alpha} and ER{beta} null mice indicate a role for ER{beta} in follicular maturation.
###end article-title 193
###begin article-title 194
Visualization of gene expression patterns by in situ hybridization.
###end article-title 194
###begin article-title 195
Isolation and characterization of posterofrontal/sagittal suture mesenchymal cells in vitro.
###end article-title 195
###begin p 196
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 196
###begin p 197
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by National Institutes of Health, National Institute of Dental and Craniofacial Research grants R01 DE-14526 and R01 DE-13194, the Oak Foundation and the Hagey Laboratory for Pediatric Regenerative Medicine to M.T.L., funding from the Division of Intramural Research of the National Institute of Environmental Health Sciences, NIH to KSK and KH. AW James is a medical student at University of California, San Francisco and was funded by the Genentech Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 197

